Parkinson's Disease Clinical Trials in New York

Showing 21-40 of 88 trials

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

NCT05308238

Pre-Active PD is a randomized controlled feasibility study to evaluate the implementation of a telehealth-delivered physical activity behavior change intervention for people with early-mid stage Parkinson's disease. The program utilizes occupational therapists to provide one-to-one individualized support to facilitate and optimize exercise uptake as part of their disease self-management. The structure of the intervention is based on previous research in neurodegenerative disease including Parkinson's disease and Huntington's disease.

Parkinson Disease

San Jose State University50 participantsStarted Apr 2022

San Jose, California, United States • New York, New York, United States

COMPLETED< 1 mile

Wearable Assessments in the Clinic and Home in PD

NCT03681015

The purpose of this study is to evaluate disease progression in persons with early Parkinson disease, as assessed by digital and electronic sensor data collection to be correlated with typical clinical assessments.

Parkinson Disease

University of Rochester132 participantsStarted Apr 2019

Sun City, Arizona, United States • San Francisco, California, United States • Aurora, Colorado, United States +14 more locations

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

Wearable Assessments in the Clinic and Home in PD

Parkinson's Disease Trials in Other Cities

Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)

Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

FoxBioNet: ECV (Extracellular Vesicle) 004

PDGeneration: Mapping the Future of Parkinson's Disease

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease

Intelligibility Assessment for Parkinson's Disease

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

IPG Replacement Study (PREFERENCE-H)

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

Other Conditions in New York